Why is the universe ripping itself apart? A new study of exploding stars shows dark energy may be more complicated than we thought 
If life exists on Jupiter’s moon Europa, scientists might soon be able to detect it 
Our survey of the sky is uncovering the secrets of how planets are born 
Larger and more frequent solar storms will make for potential disruptions and spectacular auroras on Earth 
Why some people don't trust science – and how to change their minds 
Six space missions to look forward to in 2024 
The brain is the most complicated object in the universe. This is the story of scientists’ quest to decode it – and read people’s minds 
Synthetic human embryos let researchers study early development while sidestepping ethical and logistical hurdles 
Archeoastronomy uses the rare times and places of previous total solar eclipses to help us measure history 
Alpha, beta, theta: what are brain states and brain waves? And can we control them? 
Genetic diseases: How scientists are working to make DNA repair (almost) a piece of cake 
Black hole, neutron star or something new? We discovered an object that defies explanation 
Tatahouine: 'Star Wars meteorite' sheds light on the early Solar System 
Customizing mRNA is easy, and that's what makes it the next frontier for personalized medicine − a molecular biologist explains 
Eggs from men, sperm from women: how stem cell science may change how we reproduce 
Could a telescope ever see the beginning of time? An astronomer explains 
The world has yet to find a complete cure for cancer. But scientists are continuously working in developing and improving treatment strategies. A leading research institute for cancer recently announced a new and significant effort in coming up with drugs that would help patients manage the illness and prolong their lives.
The Institute of Cancer Research, London announced on Wednesday that it is looking to invest £75 million (around $96 million) to establish a new center to house studies on “anti-evolution therapies.” The Institute aims to counter the fatal effects of cancer by tackling cancer’s ability to adapt and resist drug treatments through its new Center for Cancer Drug Discovery.
Unfortunately, the available treatment options do not always work for all cancer patients. Cancer is also known for developing the ability to adapt to drugs and become resistant leading to the formation of new tumors and making the disease highly lethal. This way, researchers will be able to come up with drug and treatment regimens that will help patients live with “manageable” conditions and ultimately allowing them to live much longer.
“Cancer’s ability to adapt, evolve and become drug resistant is the cause of the vast majority of deaths from the disease and the biggest challenge we face in overcoming it,” ICR Chief Executive Prof. Paul Workman said. “At the ICR, we are changing the entire way we think about cancer, to focus on understanding, anticipating and overcoming cancer evolution.”
The World Health Organization reported in September 2018 that there were up to 18.1 million new cases of cancer recorded. 9.6 million deaths around the world are also attributed to the inability to cure the disease. The same paper also reported that there are 43.8 million people around the world who managed to live for five years since being diagnosed with cancer.
“Unfortunately, we’re also seeing that cancer can become resistant very quickly to new drugs – and this is the greatest challenge we face,” Centre for Cancer Drug Discovery’s Head of Biology Dr. Olivia Rossanese said. “This ‘Darwinian’ approach to drug discovery gives us the best chance yet of defeating cancer, because we will be able to predict what cancer is going to do next and get one step ahead.”
